Form 4: Esquire Financial Holdings Executive Files Form 4 Detailing Stock Transactions
SEC Form 4 Filing
An executive at Esquire Financial Holdings, Ari P. Kornhaber, reported stock option exercises and the vesting of restricted stock in a recent Form 4 filing.
Summary
- Ari P. Kornhaber, an EVP at Esquire Financial Holdings, filed a Form 4 on December 10, 2024, detailing several stock transactions.
- The filing includes the acquisition of 1,777 shares of common stock at a price of $79.62.
- It also reports the vesting of 108,188 shares of restricted stock, which vest in three equal annual installments commencing on various dates from December 10, 2022, to December 15, 2027.
- Additionally, the filing notes the executive holds fully vested stock options for 7,500 shares at an exercise price of $12.50, granted on May 2, 2017, and 7,500 shares at an exercise price of $12.50, granted on September 1, 2017.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing, indicating standard executive compensation practices. There is no indication of positive or negative sentiment.
Positives
- The vesting of restricted stock indicates continued alignment of executive interests with shareholder value.
- The exercise of stock options suggests confidence in the company's future performance.
Risks
- The Form 4 filing does not indicate any immediate risks, but it is important to monitor future filings for any significant changes in executive holdings or transactions.
Industry Context
Form 4 filings are a standard part of regulatory compliance for publicly traded companies, providing transparency into executive stock transactions.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock to align management interests with shareholder value, which is a common practice across the financial industry.
- The vesting schedules for restricted stock are typical, with annual installments over a period of years.
Stakeholder Impact
- The stock transactions may have a minor impact on the stock price, but the overall impact is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 2017-05-02 | Grant date for stock options for 7,500 shares at $12.50. |
| 2017-09-01 | Grant date for stock options for 7,500 shares at $12.50. |
| 2022-12-10 | Commencement date for vesting of some restricted stock. |
| 2023-12-19 | Commencement date for vesting of some restricted stock. |
| 2024-12-10 | Date of Form 4 filing and acquisition of 1,777 shares. |
| 2024-12-16 | Commencement date for vesting of some restricted stock. |
| 2024-12-12 | Date of signature on the Form 4 filing. |
| 2025-12-09 | Commencement date for vesting of some restricted stock. |
| 2026-05-02 | Expiration date for stock options granted on May 2, 2017. |
| 2026-09-01 | Expiration date for stock options granted on September 1, 2017. |
| 2026-12-19 | Commencement date for vesting of some restricted stock. |
| 2027-12-15 | Commencement date for vesting of some restricted stock. |
Keywords
Form 4, stock options, restricted stock, executive compensation, insider trading, Esquire Financial Holdings, ESQ
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.